Rapamycin can Inhibit the Development of Chlamydia pneumoniae, which Might Partly Contribute to the Prevention of In-stent Restenosis

Y Yan, S Silvennoinen-Kassinen, M Leinonen… - … drugs and therapy, 2010 - Springer
Background Rapamycin, an immunosuppressive and antiproliferative drug, is used to
prevent neointima formation to reduce the risk of in-stent restenosis with rapamycin eluting …
被引用次数：11 相关文章

Rapamycin can Inhibit the Development of Chlamydia pneumoniae, which Might Partly Contribute to the Prevention of In-stent Restenosis

Y Yan, S Silvennoinen-kassinen… - … Drugs and Therapy, 2010 - search.proquest.com
Rapamycin, an immunosuppressive and antiproliferative drug, is used to prevent neointima
formation to reduce the risk of in-stent restenosis with rapamycin eluting-stents. Chronic …

Rapamycin can inhibit the development of Chlamydia pneumoniae, which might partly contribute to the prevention of in-stent restenosis.

Y Yan, S Silvennoinen-Kassinen… - … Drugs and Therapy, 2010 - europepmc.org
Background Rapamycin, an immunosuppressive and antiproliferative drug, is used to
prevent neointima formation to reduce the risk of in-stent restenosis with rapamycin eluting …

[引用][C] Rapamycin can Inhibit the Development of Chlamydia pneumoniae, which Might Partly Contribute to the Prevention of In-stent Restenosis

Y Yan, S Silvennoinen-Kassinen, M Leinonen… - 2010 - julkari.fi
Rapamycin can Inhibit the Development of Chlamydia pneumoniae, which Might Partly
Contribute to the Prevention of In-stent Restenosis Hyppää sisältöön Näytä/piilota sivun …

Rapamycin can inhibit the development of Chlamydia pneumoniae, which might partly contribute to the prevention of in-stent restenosis

Y Yan, S Silvennoinen-Kassinen… - … drugs and therapy, 2010 - pubmed.ncbi.nlm.nih.gov
Background Rapamycin, an immunosuppressive and antiproliferative drug, is used to
prevent neointima formation to reduce the risk of in-stent restenosis with rapamycin eluting …

Rapamycin can Inhibit the Development of Chlamydia pneumoniae, which Might Partly Contribute to the Prevention of In-stent Restenosis

Y Yan, S Silvennoinen-Kassinen, M Leinonen… - … Drugs and Therapy, 2010 - infona.pl
Background Rapamycin, an immunosuppressive and antiproliferative drug, is used to
prevent neointima formation to reduce the risk of in-stent restenosis with rapamycin eluting …

[引用][C] Rapamycin can Inhibit the Development of Chlamydia pneumoniae, which Might Partly Contribute to the Prevention of In-stent Restenosis

Y YAN, S SILVENNOINEN-KASSINEN… - … drugs and therapy, 2010 - pascal-francis.inist.fr
Rapamycin can Inhibit the Development of Chlamydia pneumoniae, which Might Partly
Contribute to the Prevention of In-stent Restenosis CNRS Inist Pascal-Francis CNRS Pascal …

[引用][C] Rapamycin can Inhibit the Development of Chlamydia pneumoniae, which Might Partly Contribute to the Prevention of In-stent Restenosis

Y Yan, S Silvennoinen-Kassinen, M Leinonen… - … Drugs and Therapy, 2010 - Springer

[引用][C] Rapamycin can Inhibit the Development of Chlamydia pneumoniae, which Might Partly Contribute to the Prevention of In-stent Restenosis

Y YAN, S SILVENNOINEN-KASSINEN… - … drugs and therapy, 2010 - Springer

[引用][C] Rapamycin can Inhibit the Development of Chlamydia pneumoniae, which Might Partly Contribute to the Prevention of In-stent Restenosis

Y Yan, S Silvennoinen-Kassinen, M Leinonen… - … drugs and therapy, 2010 - Springer